Pancreatic Cancer

• CLINICAL_TRIALS trial_result · 2025-04-22
  Clinical Trial Update: A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors [Phase 1]

  This clinical trial update reports the completion of a Phase 1 study of CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, i…

• CLINICAL_TRIALS research · 2025-04-22
  Clinical Trial Update: 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

  A clinical trial evaluating an 18F-labeled FAP-targeted molecular imaging probe for early tumor diagnosis is currently recruiting.

• CLINICAL_TRIALS research · 2025-04-22
  Clinical Trial Update: Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes

  A clinical trial evaluating adherence to Enhanced Recovery After Surgery (ERAS) protocols in pancreatic surgery and their effects on stress …

• CLINICAL_TRIALS research · 2025-04-22
  Clinical Trial Update: Wet Heparinized Suction for Abdominal Cancer [NA]

  This clinical trial update describes an investigative study of wet heparinized suction for abdominal cancers, currently not yet recruiting.

• CLINICAL_TRIALS research · 2025-04-22
  Clinical Trial Update: AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer [Phase 2]

  A Phase 2 clinical trial evaluating nimotuzumab with irreversible electroporation ablation for locally advanced pancreatic cancer; the study…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-04-22
  Clinical Trial Update: An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma [NA]

  Clinical trial update describing an ultrasound imaging technique to measure tumors in people with pancreatic ductal adenocarcinoma or gastro…

• CLINICAL_TRIALS research · 2025-04-20
  Clinical Trial Update: Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy

  A clinical trial evaluating whether an Enhanced Recovery After Surgery program improves outcomes after pancreatoduodenectomy is currently re…

• CLINICAL_TRIALS trial_result · 2025-04-18
  Clinical Trial Update: Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: [Phase 2]

  A Phase 2 trial evaluated liposomal irinotecan in combination with oxaliplatin, leucovorin, and 5-fluorouracil in locally advanced pancreati…

• CLINICAL_TRIALS trial_result · 2025-04-18
  Clinical Trial Update: Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation [Phase 1]

  Phase 1 clinical trial update of HMBD-001, an anti-HER3 antibody, evaluating its use with or without chemotherapy in solid tumors with NRG1 …

• CLINICAL_TRIALS research · 2025-04-18
  Clinical Trial Update: A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer [Phase 1]

  Phase 1 clinical trial evaluating ONO-7475 in combination with ONO-4538 and gemcitabine plus nab-paclitaxel (GnP) and ONO-7475 with GnP for …

• CLINICAL_TRIALS trial_result · 2025-04-17
  Clinical Trial Update: 2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy [Phase 3]

  A Phase 3 study evaluating second-line liposomal irinotecan (nal-IRI) after gemcitabine/nab-paclitaxel in locally advanced or metastatic pan…

• CLINICAL_TRIALS research · 2025-04-16
  Clinical Trial Update: Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer [Phase 1]

  This is a Phase 1 clinical trial evaluating the combination of trametinib and hydroxychloroquine for pancreatic cancer; the study is current…

• CLINICAL_TRIALS trial_result · 2025-04-16
  Clinical Trial Update: Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer [Phase 2]

  Clinical trial update on a Phase 2 study evaluating nab-paclitaxel and gemcitabine with or without VCN-01 in metastatic pancreatic cancer; t…

• CLINICAL_TRIALS trial_result · 2025-04-16
  Clinical Trial Update: Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC) [Phase 2]

  Phase 2 clinical trial of Enfortumab Vedotin in previously treated locally advanced or metastatic pancreatic cancer (EPIC) is active and not…

• CLINICAL_TRIALS research · 2025-04-16
  Clinical Trial Update: Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer [Phase 1]

  A Phase 1 clinical trial is evaluating the safety and tolerability of combining hydroxychloroquine and chlorphenesin carbamate with the mFOL…

• CLINICAL_TRIALS research · 2025-04-16
  Clinical Trial Update: The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer

  The document discusses the significance and indications for surgery in pancreatic cancer with synchronous liver metastases, in the context o…

• CLINICAL_TRIALS trial_result · 2025-04-10
  Clinical Trial Update: Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer [Phase 3]

  Phase 3 trial evaluating the efficacy and safety of dronabinol for chemotherapy-induced and tumor-related symptoms in patients with advanced…

• CLINICAL_TRIALS trial_result · 2025-04-10
  Clinical Trial Update: Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?

  A Kochi University-sponsored clinical trial evaluating whether recurrent pancreatic cancer has similar outcomes to primary metastatic pancre…

• CLINICAL_TRIALS trial_result · 2025-04-10
  Clinical Trial Update: Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model

  A completed clinical trial from Abramson Cancer Center at Penn Medicine evaluated an alternative genetics-based cancer care delivery model, …

• CLINICAL_TRIALS research · 2025-04-10
  Clinical Trial Update: Correlation Between Complications After Pancreaticoduodenectomy and Microbiota [NA]

  A completed study evaluating the relationship between gut microbiota and complications after pancreaticoduodenectomy in pancreatic cancer pa…

• CLINICAL_TRIALS research · 2025-04-10
  Clinical Trial Update: A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1 [Phase 1]

  This clinical trial update describes a Phase 1 study to compare the pharmacokinetics and safety of BR2021 versus BR2021-1 in patients with m…

• CLINICAL_TRIALS research · 2025-04-10
  Clinical Trial Update: A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer [Phase 1]

  A Phase 1 clinical trial evaluating CHT102 for MSLN-positive advanced pancreatic cancer is currently recruiting.

• CLINICAL_TRIALS trial_result · 2025-04-09
  Clinical Trial Update: Application of Celiac Plexus Block in Postoperative Analgesia of Whipple Surgery [Phase 4]

  A Phase 4 clinical trial evaluating celiac plexus block for postoperative analgesia in patients undergoing Whipple surgery has completed.

• CLINICAL_TRIALS research · 2025-04-09
  Clinical Trial Update: Progressive Muscle Relaxation Exercises on Sleep, Fatigue and Pain in Pancreatic and Colon Cancer Patients [NA]

  A clinical trial update notes a study evaluating progressive muscle relaxation to improve sleep, fatigue, and pain in pancreatic cancer and …

• CLINICAL_TRIALS withdrawal · 2025-04-09
  Clinical Trial Update: Study of OB-002 in Patients With Refractory Metastatic Cancer [Phase 1]

  Phase 1 study of OB-002 in various metastatic cancers has been withdrawn from clinical trials.